Hi Streamingeagle 88 and HappyLibrarian,
Streaming: Although phase 2 is suppose to be an open trial, I highly doubt NWBO would update us monthly on results. Even the results we get now from the phase 1 trial leaves many questions. What was the tumor shrinkage per patient and life expectancy on each stage 4 cancer? Which is why it is so important to know what is the primary objective for the phase 2 trial of Direct. Is it Overall Survival, tumor shrinkage or progression free survival?
HappyLibrarian and Streaming: Happylibrarian you bring up why I see Direct phase 2 trial going on for years. NWBO was constantly leaking out information about the phase 1 Direct trial till Dr. Buzargate. Now we only get information on MD Andersons terms. Which is slow, but has been good for the stock price. Bear writers have left NWBO alone for the most part and we are reaching new highs for the stock. But the slow down of information makes the final results of the phase 2 trial for direct that much more important. Early Approval will probably only be given when the trial is over and if it is overall survival as a primary endpoint it could take years.
The reason, I am a strong believer in following DcVax L is because if the phase 3 is successful than investors will be talking about future profits from selling the product in other countries to raise the stock price. Not how Direct is doing in its trial.